ID
20439
Description
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00899197
Link
https://clinicaltrials.gov/show/NCT00899197
Keywords
Versions (1)
- 2/22/17 2/22/17 -
Uploaded on
February 22, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00899197
Eligibility Breast Cancer NCT00899197
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
hemoglobin, severe anemia
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019046
- UMLS CUI [1,2]
- C0238644
Description
psychiatric history, informed consent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0748059
- UMLS CUI [1,2]
- C0021430
Similar models
Eligibility Breast Cancer NCT00899197
- StudyEvent: Eligibility
C0679557 (UMLS CUI [1,2])
C1517925 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0677850 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0449438 (UMLS CUI [1,2])
C0238644 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])